Century Therapeutics
Drug Discovery
Century Therapeutics valuation and funding history | Last updated: February 1, 2021 | 2 funding rounds
Current Valuation
N/A
As of February 1, 2021
Total Funding Raised
N/A
Across 2 rounds
Last Round
Later Stage VC (Series C)
$160.0M
Last Funding
Feb 2021
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| February 1, 2021 | Later Stage VC (Series C) | $160.0M | N/A | - |
| January 8, 2026 | PIPE | $135.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Century Therapeutics is currently valued at N/A as of February 1, 2021.
What is Century Therapeutics Worth in 2026?
Century Therapeutics is a leading private company in the Drug Discovery sector. Track Century Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Century Therapeutics Valuation is Determined
Private company valuations like Century Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.